Management of high-grade bone sarcomas over two decades: The Norwegian Radium Hospital experience

References

• Bauer HC, Alvegard TA, Berlin O, et al. The Scandinavian Sarcoma Group Register. Acta Orthop Scand 1999; 70(Suppl 285)41–4
   Google Scholar
• Alvegard, TA, Rydholm, A. The Scandinavian Sarcoma Group. Twenty years experience. Acta Orthop Scand 1999;70, (Suppl 285).
   PubMedGoogle Scholar
• Unni KK, Dahlin DC. Grading of bone tumors. Semin Diagn Pathol 1984; 1: 165–17
   PubMedGoogle Scholar
• Inwards CY, Unni KK. Classification and grading of bone sarcomas. Hematol Oncol Clin North Am 1995; 9: 545–69
   PubMed Web of Science ®Google Scholar
• Saeter G, Alvegard TA, Elomaa I, Stenwig AE, Holmstrom T, Solheim OP. Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: A Scandinavian Sarcoma Group study. J Clin Oncol 1991; 9(10)1766–75
   PubMedGoogle Scholar
• Saeter G, Wiebe T, Wiklund T, et al. Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience. Acta Orthop Scand 1999; 70(Suppl 285)74–82
   Google Scholar
• Smeland S, Muller C, Alvegard TA, et al. Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: Prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders. Eur J Cancer 2003; 39: 488–94
   PubMed Web of Science ®Google Scholar
• Bacci G, Ferrari S, Longhi A, et al. High dose ifosfamide in combination with high dose metothrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma:preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot study. J Chemother 2002; 14(2)198–206
   PubMed Web of Science ®Google Scholar
• Smeland, S, Bacci, G, Ferrari, S, et al. Neoadjuvant chemotherapy with high-dose ifosfamide added to methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity. A joint study by the Italian (ISG) and Scandinavian sarcoma groups. Proceedings of ASCO 2003;22:817, (abstr).
   Google Scholar
• Nilbert M, Saeter G, Elomaa I, et al. Ewing's sarcoma treatment in Scandinavia 1984–1990–ten-year results of the Scandinavian Sarcoma Group Protocol SSGIV. Acta Oncol 1998; 37: 375–8
   PubMed Web of Science ®Google Scholar
• Elomaa I, Blomqvist CP, Saeter G, et al. Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol. Eur J Cancer 2000; 36: 875–80
   PubMed Web of Science ®Google Scholar
• Rosito P, Mancini AF, Rondelli R, et al. Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: A preliminary report of 6 years of experience. Cancer 1999; 86: 421–8
   PubMed Web of Science ®Google Scholar
• Bruland OS, Pihl A. On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy. Eur J Cancer 1997; 33: 1725–31
   PubMed Web of Science ®Google Scholar
• Stiller CA. Survival of patients with cancer. Those included in clinical trials do better. BMJ 1989; 299: 1058–9
   PubMedGoogle Scholar
• Elomaa I, Blomqvist C, Saeter G, et al. Chemotherapy in Ewing's sarcoma. The Scandinavian Sarcoma Group experience. Acta Orthop Scand 1999; 70(Suppl 285)69–73
   Google Scholar
• Rodriguez-Galindo C, Spunt SL, Pappo AS. Treatment of Ewing sarcoma family oftumors:current status and outlook for the future. Med Pediatr Oncol 2003; 40: 276–87
   PubMedGoogle Scholar
• Burdach S, Meyer-Bahlburg A, Laws HJ, et al. High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: Results of two consecutive regimens assessing the role of total-body irradiation. J Clin Oncol 2003; 21: 3072–8
   PubMed Web of Science ®Google Scholar
• Saeter G, Høie J, Stenwig AE, et al. Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival. Cancer 1995; 75: 1084–93
   PubMed Web of Science ®Google Scholar
• Gobel V, Jurgens H, Etspuler G, et al. Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents. J Cancer Res Clin Oncol 1987; 113: 187–91
   PubMed Web of Science ®Google Scholar
• Sæter G, Bruland ØS, Follerås G, et al. Extremity and non-extremity high-grade osteosarcoma. The Norwegian Radium Hospital experience during the modern chemotherapy era. Acta Oncol 1996; 35(Suppl 8)129–34
   PubMedGoogle Scholar